Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niraparib with Radiotherapy for Metastatic Cervical Cancer
NCT03644342Phase 2Terminated
- Start
- Jul 2019
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of niraparib in Cervical Cancer (CC). Started Jul 2019; status: terminated.
02
Drugs
niraparib
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT03644342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03644342.